Products

Our products

Learn more about our product portfolio and how we're prioritising vaccines and specialty medicines to get ahead of disease together.

Close Video

Our product areas

Our portfolio spans three product areas: vaccines, specialty and general medicines. Globally, we’re prioritising R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.

Our focus brands across vaccines, specialty and general medicines

Unrivalled Vaccine Portfolio of GSK India

Vaccines

Globally, our unrivalled vaccine portfolio targets infectious diseases at every stage of life. From adjuvants that improve vaccine effectiveness, through to mRNA technology, we use advanced technologies and collaborate with our partners to develop new, more effective vaccines that help people around the world to get ahead of disease.

Infanrix Hexa

Indicated for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by Haemophilus influenzae type B
Powder and suspension for injection in intramuscular use
Ranked No. 1 in the segment*
Trusted among paediatricians
Market leader in DTP Hexavalent vaccine category* with over two decades of market presence
Registered in over 90 countries

Synflorix

Indicated for active immunisation of infants against pneumococcal diseases and acute otitis media caused by Streptococcus pneumoniae and Non-Typeable Haemophilus influenzae
Injectable suspension for intramuscular use
Ranked No. 2 in the segment*
Trusted for over 10 years in more than 130 countries
More than 20 crore babies protected against pneumococcal diseases and AOM caused by S. Pneumoniae and NTHi

Havrix

Indicated for active immunisation against disease caused by Hepatitis A virus (HAV) from 1+ year of age
Injectable suspension for intramuscular use
Ranked No. 2 in the segment*
Rapid seroconversion and at least 50 years of long-term protection against Hepatitis A
Most widely studied Hepatitis A vaccine registered in over 90 countries

Menveo

Indicated for active immunisation from 2 years of age to prevent invasive meningococcal disease caused by Neisseria Meningitidis groups A, C, W-135 and Y
Powder and solution for injection in intramuscular use
Over 10 years of global experience and approved in the US and the EU countries

Boostrix

Indicated for active booster immunisation against diphtheria, tetanus and pertussis in individuals aged 4+ years
Injectable suspension for intramuscular use
It is the only Tdap vaccine approved by the FDA for adults aged 65+ years and can be given to pregnant mothers also
Ranked No. 1 in the segment*
Boostrix is India’s first and trusted Tdap vaccine

Fluarix Tetra

Indicated for active immunisation from age group of 6 months and older for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus lineages contained in the vaccine
For injection in intramuscular use
Ranked No. 2 in the segment*
World’s first inactivated quadrivalent influenza vaccines (QIV) which is manufactured in Germany
Over 24 crore doses sold worldwide

Varilrix

Indicated for active immunisation against varicella of healthy subjects
Powder and solvent for solution for injection to be given subcutaneously
Ranked No. 1 in the segment*
World’s first varicella vaccine with robust and proven efficacy data
Registered in over 90 countries, trusted worldwide with more than 30 years of experience

Shingrix

Shingrix is indicated for prevention of Shingles and Post herpetic neuralgia in individuals >50 years of age
First Non-live, adjuvanted, recombinant vaccine for prevention of shingles
It is approved in 50 countries and is a part of 24 National recommendations

Specialty medicines

As our experts seek innovative new ways to treat the human body, specialty medicines are at the forefront of our high-value pipeline of new products. We are global leaders in developing medicines for respiratory disease and HIV, and we are building our presence in other therapeutic areas such as immunology and oncology.

In India, our Specialty medicines are focussed on helping patients breathe easy through innovative offerings that combine science and technology.

Our Specialty medicines in India

NUCALA

First anti-IL5 drug in India
Indicated for adults suffering from severe eosinophilic asthma (SEA)
Launched Nucala auto-injector device for easier self-administration

TRELEGY ELLIPTA

First once-daily single-inhaler triple therapy (SITT) in India for the maintenance treatment of chronic obstructive pulmonary disease (COPD) patients

General medicines

General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. Globally, this includes our medicines for inhaled respiratory, dermatology and other diseases. These vital medications are the engine room for GSK, supporting hundreds of millions of people to enjoy a better everyday quality of life.

In India, our general medicines business has a broad portfolio of established medicines with commercial leadership in anti-infectives, pain, dermatology and vitamins.

AUGMENTIN

Augmentin (Amoxicillin-Clavulanic acid) is a broad spectrum prescription antibiotic used to treat various bacterial infections
Ranked No. 1 in the segment*
Setting standards for quality and innovation for over four decades

CALPOL

Indicated for treatment of mild to moderate pain
Calpol is the No. 1 prescribed brand in the Indian Pharmaceuticals Market (IPM)*
Ranked No. 1 in the segment*

CEFTUM

Ceftum (Cefuroxime) is a second generation cephalosporin antibiotic being used for over two decades to treat various bacterial infections
Ranked No. 1 in the segment*

ELTROXIN

Serving patients with hypothyroidism since 1950
Ranked No. 2 in the segment*

Indicated for the treatment of calcium and vitamin D deficiency states (particularly pregnant and lactating women and children)
Ranked No. 1 in the segment* (calcium citrate maleate salt segment)

NEOSPORIN

Indicated for treatment and prevention of specific bacterial skin infections
Also available for topical ophthalmic use
Neosporin has been a trusted brand for over five decades
• Ranked No. 3 in the segment*

BETNOVATE

Betnovate (Betamethasone valerate) is a potent topical corticosteroid used for specific type of skin conditions which require relief of inflammation
• India’s No. 1 brand in topical corticosteroid category
Serving patients since 1963

T-BACT

Indicated for topical use in specific types of bacterial skin infections
No. 1 prescribed topical antibiotic with strong equity amongst healthcare professionals

TENOVATE

Tenovate (Clobetasol propionate) is a super potent topical corticosteroid indicated for specific type of skin conditions to reduce inflammation
No. 1 prescribed brand in the category*
Ranked No. 1 in the segment*

FLUTIVATE

Flutivate (Fluticasone propionate) is a potent topical corticosteroid indicated for specific type of skin conditions to reduce inflammation
Helping patients regain skin confidence for over two decades
Ranked No. 1 in the segment*

PHYSIOGEL

Indicated for dry skin and dry skin associated with redness and itch
Ranked No. 10 in the segment*
Physiogel works for stronger, smoother and visibly healthier skin

ZIMIG

Zimig (Terbinafine) is an antifungal agent used for specific types of fungal skin infections available as oral and topical formulation
Ranked No. 2 in the segment by value*
Serving Indian patients for more than a decade

COBADEX CZS

Multivitamin with zinc combination, including 4 essential B-vitamins and trace elements of chromium, zinc and selenium
Ranked No. 7 in the category*
Prescribed by more than 30,000 HCPs

SUPACEF

Supacef is a bactericidal cephalosporin antibiotic
Indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria
Ranked No. 1 in the category*